1 Min Read
Aug 22 (Reuters) -
* jupiter Orphan Therapeutics Inc says receives orphan drug designation for its trans-resveratrol product Jotrol for treatment of Friedreich’s Ataxia Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.